JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266285

Human NDUFC1 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

NDUFC1 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon 2 and 5 bp deletion in exon 2.

View Alternative Names

CI-KFYI, Complex I KFYI subunit, Complex I-KFYI, KFYI, NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa, NADH dehydrogenase [ubiquinone] 1 subunit C1, NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial, NADH-ubiquinone oxidoreductase KFYI subunit, NDUC1_HUMAN, mitochondrial

2 Images
Sanger Sequencing - Human NDUFC1 knockout HEK-293T cell line (AB266285)
  • Sanger seq

Unknown

Sanger Sequencing - Human NDUFC1 knockout HEK-293T cell line (AB266285)

Allele-2 : 5 bp deletion in exon 2.

Sanger Sequencing - Human NDUFC1 knockout HEK-293T cell line (AB266285)
  • Sanger seq

Unknown

Sanger Sequencing - Human NDUFC1 knockout HEK-293T cell line (AB266285)

Allele-1 : 14 bp deletion in exon 2

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 14 bp deletion in exon 2 and 5 bp deletion in exon 2

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266285-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266285 Human NDUFC1 knockout HEK-293T cell line", "number":"AB266285-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266285-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266285 Human NDUFC1 knockout HEK-293T cell line", "number":"AB266285-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
NDUFC1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

NDUFC1 also called NADH:ubiquinone oxidoreductase subunit C1 contributes to the mitochondrial respiratory chain specifically as a subunit of complex I. The protein weighs around 11 kDa and exists in the inner mitochondrial membrane. NDUFC1 participates in transferring electrons from NADH to ubiquinone playing an essential role in cellular energy production. It shows expression across various tissues supporting its wide functional significance.
Biological function summary

The electron transport chain relies on NDUFC1 for its operation as it is part of the large complex I assembly. NDUFC1 contributes by aiding the proton pump activity of complex I which is part of oxidative phosphorylation. Complex I includes about 45 subunits with NDUFC1 playing a supportive function in stabilizing this intricate structure. This efficient electron transfer and proton gradient generation drive ATP synthesis important for energy metabolism.

Pathways

Chemo-osmotic coupling in oxidative phosphorylation processes heavily relies on functional complex I and its components like NDUFC1. NDUFC1 facilitates the initial steps in the electron transport chain. It works alongside proteins such as NDUFA1 and NDUFB5 within the complex to ensure proper electron flow from NADH to ubiquinone. This integration into the oxidative phosphorylation pathway links it to other cellular processes including metabolism and reactive oxygen species regulation.

NDUFC1 often appears in discussions around mitochondrial disorders notably mitochondrial complex I deficiency which impacts energy production in cells. Mutations or dysfunctions in NDUFC1 can also contribute to neurodegenerative diseases like Leigh syndrome where defective oxidative phosphorylation leads to disrupted cellular functions. Within these disease contexts NDUFC1 interacts with proteins such as NDUFS1 in the context of complex I to influence disease severity and progression.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com